The purpose of this study is to describe ways in which a histopathology data pool can be used to provide simple epidemiological information on disease patterns. Analysis of data pool material has been advocated as a means of measuring quality assurance in histopathology.1 If such an approach is feasible, it is important to compare the consistency of the stored data with available sources of information. In this paper an attempt has been made to assess the quality of the stored data and to identify areas where improvements are required which would widen the potential value of such data pools.
Since its inception in 1970, the Birmingham Histopathology Data Pool (BHDP) has acquired a large volume of coded histological data, and significant numbers of both common and rare lesions are on file. Details of the project, which uses the Systematised Nomenclature of Pathology (SNOP)2 for coding histopathological material have been described previously.3 For this study, coded data on several types of cutaneous neoplasms and various hepatic inflammatory lesions have been selected for analysis. The resulting information has been compared with available information from the Birmingham Cancer Registry.4 The results indicate that histopathology data pools have considerable potential with the advantage of providing information on benign neoplasms and non-neoplastic conditions.
Material and methods
The details of computer facilities, data input, processing, and routine output together with the Received for publication 8 October 1979 contributing laboratories have been described.3 For this study, retrievals of specific lesions were selected in either SNOP anatomical (skin neoplasms) or morphological (hepatic lesions) order. The cutaneous neoplasms, with equivalent SNOP morphological codes in parentheses, were squamous carcinoma (M8073), in-situ squamous carcinoma including Bowen's disease (M8072 and M8082), and various naevi and melanomas (M872-to M879-). The hepatic lesions selected were sarcoidosis (M4454), granulomatous inflammation not otherwise specified but excluding sarcoid (M44--), chronic inflammation (M43--), inflammation not otherwise specified, acute and subacute (M4---to M42--), alcoholic cirrhosis (M4851 E5510), cirrhosis excluding alcoholic cirrhosis (M4850-M4861), and biliary cirrhosis (M4852). Retrievals were based on the whole data pool content for the years 1970 to 1977 inclusive. Multiple listings of the same lesion, coded as occurring at the same anatomical site in the same patient, were eliminated before analysis. Although data retrievals for skin neoplasms split the anatomical site of the lesions into multiple topographical areas the data have been regrouped into major sites for ease of presentation.
In a small proportion of cases of skin neoplasms the topographical site was not assigned and coded as skin, not otherwise specified (TO100). These cases are excluded from data on site distributions.
The 
SITE DISTRIBUTION OF CUTANEOUS NEOPLASMS
In view of the similar age and sex structures of the two series it is not surprising that the site distributions of the various neoplasms are similar. Table 2 shows the topographic distribution of squamous carcinoma. In both sources the upper limb in males and the lower limb in females are important sites for squamous carcinoma. This sex difference is further illustrated by examining the sex ratios of cases at different sites on the body (Table 2) . Similar trends are shown in data from the BHDP on in-situ carcinoma (Table 3) . Table 4 shows the topographical distribution and sex ratios for basal cell carcinoma. Both series show similar features.
The anatomical distribution of cases of malignant melanoma together with sex ratios are shown in Table 5 . Again, apart from the trunk in males, the data are similar and also show the importance of the lower limb in females as a site of occurrence. Topographic distributions of four types of benign naevi recorded in the BHDP are shown in Table 6 . All types of benign naevi showed a marked female predominance apart from intradermal naevi where the sex ratio was almost unity. The mean age of male and female cases of intradermal naevi was significantly higher (P < 0-001) than for other benign naevi. Interesting features from this table are the importance of the trunk and lower limbs as recorded sites of occurrence of junctional naevi and the trunk as a site for compound naevi. Blue naevi were recorded most frequently on the upper limb in females but, curiously, the head and neck was the most frequent site in males. Data for juvenile melanoma are not shown as numbers were small (see Table 1 ) but showed a slight tendency for the trunk to be the most frequent topographical site assigned.
Other diagnoses recorded in the data pool included 12 cases of naevus not otherwise specified (M8720), nine cases of cellular naevi (M8790), and one malignant blue naevus recorded on the upper limb.
NON-ASSIGNED CASES
The number of cases where the anatomical site of a neoplasm was not assigned was small. For London5 and Glasgow,6 although the latter series differs with regard to the site distribution in males.
As far as we are aware, no comparable data are available for benign pigmented naevi. In one published series7 of excised naevi, 50% occurred on the head and neck and 16% on the lower limbs. However, no information was given on the sex distribution of the series nor were the lesions categorised into dilferent histological subtypes.
Obviously the figures of surgically excised naevi from the BHDP in no way reflect the overall incidence of these lesions in the general population, and the removal of naevi for cosmetic reasons is likely to influence sampling. Despite (2) miscoding by the pathologist (3 %), and (3) coding similar lesions in different ways due to inherent choice in the SNOP system (3 %). By choosing welldefined cutaneous morphological entities for our analysis, errors due to the third factor are likely to be low. In contrast, the error rate in the hepatic lesions due to coding choice is likely to be much higher for the reasons discussed in the previous section.
In so far as all histological diagnoses made on surgical biopsy specimens examined in contributing laboratories are stored in the data pool, the information is complete. However, in two areas the data are deficient.
The first deficiency relates to the proportion of cases of cutaneous neoplasms where a topographical site was not assigned. For most of the neoplasms these cases constituted a small proportion of the overall numbers and probably would not significantly affect data on site distribution. The exceptions were cases coded as junctional naevi where 8.4% of male cases were not assigned specific topographic codes. This may have distorted the site frequency.
The second deficiency in our data is more major and relates to the potential use of histopathology data pools for providing incidence figures of lesions in the population. In contrast to the Cancer Registry, the Data Pool as constituted at present does not collect information from a defined geographical region. Despite the lack of a defined population base comparison between the sources shows a large measure of agreement. Apart from quality assurance, histopathology data pools could give potentially valuable epidemiological information on diseases and be used to assess the impact of new investigative techniques on rates of diagnosis. With the decline in necropsy rates, this type of approach could be of immense value in assessing trends in both neoplastic and non-neoplastic conditions, provided current limitations can be overcome. If a histopathology data bank is to fulfil this potential, it is apparent that it should serve a defined hospital or geographical population where possible, and it is important that coding practice should be made uniform.
